RNTX
Rein Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.30
+0.02 ▲ +1.56%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$1.30
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.64 | Insider Own | 6.61% | Shs Outstand | 0.03B | Perf Week | 8.33% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | 30.9% | Shs Float | 0.02B | Perf Month | 10.17% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | - | Inst Own | 34.65% | Short Float | 1.82% | Perf Quarter | -12.75% |
| Income | -0.06B | P/S | - | EPS this Y | 73.5% | Inst Trans | 3.03% | Short Ratio | 3.19 | Perf Half Y | 20.37% |
| Sales | 0.00B | P/B | 27.58 | EPS next 5Y | - | ROA | -74.57% | Short Interest | 0.45M | Perf YTD | 12.07% |
| Book/sh | 0.05 | P/C | 8.44 | EPS past 3/5Y | 15.9% 31.9% | ROE | -83.28% | 52W High | -45.83% ($2.40) | Perf Year | -35.64% |
| Cash/sh | 0.15 | P/FCF | - | Sales past 3/5Y | - | ROIC | -127.48% | 52W Low | 27.45% ($1.02) | Perf 3Y | -0.85% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 15.35% | Gross Margin | - | Volatility(W/M) | 8.9% 9.3% | Perf 5Y | -96.01% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.11 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.9 | EPS Q/Q | 21.56% | Profit Margin | - | RSI (14) | 58.89 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.9 | Sales Q/Q | - | SMA20 | 8.7% ($1.2) | Beta | 1.46 | Target Price | $10 |
| Payout | - | Debt/Eq | 0 | Earnings | 2025/11/14 | SMA50 | 5.91% ($1.23) | Rel Volume | 0.32 | Prev Close | $1.28 |
| Employees | 11 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 12.5% - | SMA200 | -3.97% ($1.35) | Avg Volume(3M) | 0.14M | Price | $1.3 |
| IPO | 2017/6/29 | Option/Short | No/Yes | Trades | 296 | Volume | 44,298 | Change | 1.56% |
뉴스 로딩 중...